HTA Review Committee

EXCITE uses select members from Ontario Health Technology Advisory Committee (OHTAC) to participate on a subcommittee for the EXCITE process. This subcommittee is involved during the application phase by screening applications from the perspective of the Ontario health system, such that only those technologies with a reasonable likelihood health system impact, based on supportive data, will receive a positive recommendation to the EXCITE Board for selection into the EXCITE Program. Before evaluations begin, the HTA Review Committee is consulted to ensure that the evaluation proposal is designed to produce evidence that will effectively answer questions relevant to the Ontario health system’s criteria in making an adoption decision for the technology in the post-market space.

For more information on OHTAC, please click here.